Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
45 Million
(Quarterly Results - Jun 2025)
Net Profit:
7 Million
Pharmaceuticals & Biotechnology
ILS 1,091 Million ()
51.00
NA
0.00%
-0.99
9.61%
4.71






